Article | January 20, 2021

Establishing A Remote Audit Process As A CDMO

By Adara Kurtz, Quality Assurance Manager, Singota, Jerrad Tosti, Quality Assurance Supervisor, Singota, Patti Fiscus, Quality Assurance Supervisor, Singota Solutions

Virtual Covid 19 Clinical Trial

The effects of the pandemic have been far reaching within the pharmaceutical industry and compliance audits have not been immune. Widespread travel restrictions and adjusted visitor policies have prevented standard onsite audits from occurring. As a CDMO, Singota has excelled at providing clients with transparent and robust compliance audits. This has historically been achieved through onsite visits and face-to-face interactions. Due to current events, Singota has been required to adapt quickly to the changing environment to maintain a high level of service while protecting employee and client safety.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma